Healthcare - Biotechnology - NASDAQ - US
$ 0.1311
-6.36 %
$ 24.5 M
Market Cap
0.0
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
203.37%
EBIT
Estimate
51.98%
Net Income
Estimate
19.08%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Tonix Pharmaceuticals Holding Corp.
TNXP has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TNXP
EBIT FORECAST
EBIT Forecast Chart TNXP
NET INCOME FORECAST
Net Income Chart TNXP